About Us
Focus on the development of new antibody drugs for the treatment of tumors and autoimmune inflammatory diseases

About Us

Core Team

WANG Yaning

Chief Executive Officer

30 years’ experience at pharmaceutical companies

Rich experience in the development and management of biopharmaceutical research and development teams

Senior Vice President of Qilu Pharmaceutica

Clinical Medicine Degree from Peking University School of Medicine

Master's degree in Pharmacology from the University of Kentucky


Chief Medicine officer

17 years’ experience at international pharmaceutical companies

10 years’ clinical practice, trained nephrologist and Medical university lecturer

TA head, Great China at AbbVie Co. Ltd.

Head of translational medicine at I-MAB pharma

Head of Infectious Disease and Vaccine at Johnson & Johnson R&D and Scientific Affairs

M.D., Ph.D., Visiting scholar at Karolinska University, Sweden

Ph.D Renji hospital, Shanghai 2nd Medical University

Li Guo, Ph.D.

Vice President of R&D

Over 15 years of antibody drug R&D experience

Principle Scientist of China R&D Center at Novo Nordisk
Led a global cross-function team
Published 4 international patents on antibody drugs
Ph.D. from Chinese Academy of Sciences, postdoc at Harvard University

Eric Wu, Ph.D., MBA

Vice President of Business Development and Operations

15 years of medical research and business development experience

Deep knowledge of both US and China healthcare industries
Director of business development at Reistone Biopharma 

International business development manager at Qilu-Pharma  

Ph.D. from Texas A&M University,

M.B.A from New York University

Jianguo You

Vice President of Clinical Operations

17 years of clinical trial operation and management experiences
Managed more than 100 Clinical Trials 
COO of Clinical Medical Center at Qingfeng Pharmaceutical Group

VP/COO of clinical operations at Microconstants

MPH from Peking University Health Science Center

Xiaowei Li Ph.D.

Senior Director of CMC

10 years of antibody drug research and development experience

7 years of in drug CMC and project management experience

Senior Director of R&D at Staidson Biopharma

Ph.D. from Peking University / Nagasaki International University, Japan

Postdoc at Zhejiang Hisun Pharmaceutical



Zhong Guancun Biopharmaceutical Park, NO.5 Kaituo Road,

Haidian District, Beijing City, China, 10084

A1 Northern Building, 218 Xinghu St. Suzhou Industrial Park, Jiangsu Province, China, 215123

COPYRIGHT @2020 Suzhou xinkanghe Biomedical Technology Co., Ltd   苏ICP备19068714号-1   Power by 300.cn Beijing


Follow us